EarningsSILCOPHL
SILCOPHL Earnings Update
Announcement summary
- What happened
- SILCOPHL published a corporate disclosure on 17 May 2022. Read the full announcement for details.
- Company
- Silco Pharmaceuticals Limited
- Announcement published
Original announcement
(Q3 Un-audited): EPS was Tk. 0.33 for January-March 2022 as against Tk. 0.32 for January-March 2021; EPS was Tk. 0.80 for July 2021-March 2022 as against Tk. 0.77 for July 2020-March 2021. NOCFPS was Tk. 1.31 for July 2021-March 2022 as against Tk. 1.79 for July 2020-March 2021. NAV per share was Tk. 21.98 as on March 31, 2022 and Tk. 21.85 as on June 30, 2021.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 62832109cf6229bc6ae5dab5
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SILCOPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.